Your browser doesn't support javascript.
loading
Which patients with asthma are most likely to benefit from allergen immunotherapy?
de Blay, Frédéric; Gherasim, Alina; Casale, Tomas B; Doyen, Virginie; Bernstein, David.
Afiliación
  • de Blay F; Chest Diseases Department, Strasbourg University Hospital, Strasbourg, France; ALYATEC Environmental Exposure Chamber, Strasbourg, France; Federation of Translational Medicine EA 3070, University of Strasbourg, France. Electronic address: frederic.deblay@chru-strasbourg.fr.
  • Gherasim A; ALYATEC Environmental Exposure Chamber, Strasbourg, France.
  • Casale TB; University of South Florida Tampa, Fla.
  • Doyen V; Chest Diseases Department, Strasbourg University Hospital, Strasbourg, France; Laboratory of Translational Research, ULB223, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
  • Bernstein D; Division of Immunology, Allergy and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
J Allergy Clin Immunol ; 149(3): 833-843, 2022 03.
Article en En | MEDLINE | ID: mdl-35081376

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / Inmunoterapia Sublingual / Rinitis Alérgica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / Inmunoterapia Sublingual / Rinitis Alérgica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article